FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3084656137> ?p ?o ?g. }

• W3084656137 endingPage "609" @default.
• W3084656137 startingPage "593" @default.
• W3084656137 abstract "Deferoxamine mesylate (DFO) is an FDA-approved, hexadentate iron chelator routinely used to alleviate systemic iron burden in thalassemia major and sickle cell patients. Iron accumulation in these disease states results from the repeated blood transfusions required to manage these conditions. Iron accumulation has also been implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), and secondary injury following intracerebral hemorrhage (ICH). Chelation of brain iron is thus a promising therapeutic strategy for improving behavioral outcomes and slowing neurodegeneration in the aforementioned disease states, though the effectiveness of DFO treatment is limited on several accounts. Systemically administered DFO results in nonspecific toxicity at high doses, and the drug's short half-life leads to low patient compliance. Mixed reports of DFO's ability to cross the blood-brain barrier (BBB) also appear in literature. These limitations necessitate novel DFO formulations prior to the drug's widespread use in managing neurodegeneration. Herein, we discuss the various dosing regimens and formulations employed in intranasal (IN) or systemic DFO treatment, as well as the physiological and behavioral outcomes observed in animal models of AD, PD, and ICH. The clinical progress of chelation therapy with DFO in managing neurodegeneration is also evaluated. Finally, the elimination of intranasally administered particles via the glymphatic system and efflux transporters is discussed. Abundant preclinical evidence suggests that intranasal DFO treatment improves memory retention and behavioral outcome in rodent models of AD, PD, and ICH. Several other biochemical and physiological metrics, such as tau phosphorylation, the survival of tyrosine hydroxylase-positive neurons, and infarct volume, are also positively affected by intranasal DFO treatment. However, dosing regimens are inconsistent across studies, and little is known about brain DFO concentration following treatment. Systemic DFO treatment yields similar results, and some complex formulations have been developed to improve permeability across the BBB. However, despite the success in preclinical models, clinical translation is limited with most clinical evidence investigating DFO treatment in ICH patients, where high-dose treatment has proven dangerous and dosing regimens are not consistent across studies. DFO is a strong drug candidate for managing neurodegeneration in the aging population, but before it can be routinely implemented as a therapeutic agent, dosing regimens must be standardized, and brain DFO content following drug administration must be understood and controlled via novel formulations." @default.
• W3084656137 created "2020-09-21" @default.
• W3084656137 creator A5049298462 @default.
• W3084656137 creator A5083635208 @default.
• W3084656137 date "2020-09-14" @default.
• W3084656137 modified "2023-10-18" @default.
• W3084656137 title "Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage" @default.
• W3084656137 cites W1178578580 @default.
• W3084656137 cites W142309841 @default.
• W3084656137 cites W1480108665 @default.
• W3084656137 cites W1488734028 @default.
• W3084656137 cites W1493307838 @default.
• W3084656137 cites W1508884137 @default.
• W3084656137 cites W1510941488 @default.
• W3084656137 cites W1572920194 @default.
• W3084656137 cites W1575995714 @default.
• W3084656137 cites W1902785172 @default.
• W3084656137 cites W1915802091 @default.
• W3084656137 cites W1940373865 @default.
• W3084656137 cites W1963526238 @default.
• W3084656137 cites W1963873731 @default.
• W3084656137 cites W1963945544 @default.
• W3084656137 cites W1964271667 @default.
• W3084656137 cites W1966539317 @default.
• W3084656137 cites W1967270755 @default.
• W3084656137 cites W1968092825 @default.
• W3084656137 cites W1970096539 @default.
• W3084656137 cites W1970715454 @default.
• W3084656137 cites W1972755751 @default.
• W3084656137 cites W1972979183 @default.
• W3084656137 cites W1974135645 @default.
• W3084656137 cites W1975308400 @default.
• W3084656137 cites W1976194786 @default.
• W3084656137 cites W1977131953 @default.
• W3084656137 cites W1981934553 @default.
• W3084656137 cites W1982413610 @default.
• W3084656137 cites W1982487069 @default.
• W3084656137 cites W1986757417 @default.
• W3084656137 cites W1987820290 @default.
• W3084656137 cites W1989031118 @default.
• W3084656137 cites W1990282151 @default.
• W3084656137 cites W1996241764 @default.
• W3084656137 cites W2001525797 @default.
• W3084656137 cites W2004628001 @default.
• W3084656137 cites W2005868568 @default.
• W3084656137 cites W2006016787 @default.
• W3084656137 cites W2006221702 @default.
• W3084656137 cites W2006250045 @default.
• W3084656137 cites W2006358233 @default.
• W3084656137 cites W2008516570 @default.
• W3084656137 cites W2009978681 @default.
• W3084656137 cites W2012933242 @default.
• W3084656137 cites W2014817776 @default.
• W3084656137 cites W2018340655 @default.
• W3084656137 cites W2019286511 @default.
• W3084656137 cites W2019867783 @default.
• W3084656137 cites W2021348357 @default.
• W3084656137 cites W2024848348 @default.
• W3084656137 cites W2026291412 @default.
• W3084656137 cites W2031473278 @default.
• W3084656137 cites W2038591260 @default.
• W3084656137 cites W2039403847 @default.
• W3084656137 cites W2040991500 @default.
• W3084656137 cites W2044682044 @default.
• W3084656137 cites W2050030843 @default.
• W3084656137 cites W2051575873 @default.
• W3084656137 cites W2054113864 @default.
• W3084656137 cites W2056606238 @default.
• W3084656137 cites W2061739870 @default.
• W3084656137 cites W2062851065 @default.
• W3084656137 cites W2065268020 @default.
• W3084656137 cites W2066734010 @default.
• W3084656137 cites W2073394985 @default.
• W3084656137 cites W2076066796 @default.
• W3084656137 cites W2083064250 @default.
• W3084656137 cites W2083500052 @default.
• W3084656137 cites W2084272059 @default.
• W3084656137 cites W2085106089 @default.
• W3084656137 cites W2085842761 @default.
• W3084656137 cites W2086096852 @default.
• W3084656137 cites W2087390633 @default.
• W3084656137 cites W2087560082 @default.
• W3084656137 cites W2093239104 @default.
• W3084656137 cites W2094992383 @default.
• W3084656137 cites W2100919899 @default.
• W3084656137 cites W2104290477 @default.
• W3084656137 cites W2106146695 @default.
• W3084656137 cites W2106536537 @default.
• W3084656137 cites W2107405263 @default.
• W3084656137 cites W2110796758 @default.
• W3084656137 cites W2112232230 @default.
• W3084656137 cites W2112587738 @default.
• W3084656137 cites W211905087 @default.
• W3084656137 cites W2124100859 @default.
• W3084656137 cites W2134804946 @default.
• W3084656137 cites W2139254934 @default.
• W3084656137 cites W2144625075 @default.
• W3084656137 cites W2153002415 @default.

• next